Research programme: gene therapies - Enzo Biochem
Latest Information Update: 17 Jun 2014
At a glance
- Originator Enzo Biochem; Enzo Therapeutics
- Class Gene therapies
- Mechanism of Action Gene transference
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Unspecified
Most Recent Events
- 17 Jun 2014 Preclinical trials in Undefined indication in USA (Parenteral)